Novartis AG (NVS)
93.91
+1.34
(+1.45%)
USD |
NYSE |
Apr 19, 12:16
Novartis Shareholders Equity (Quarterly): 46.67B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 46.67B |
| September 30, 2023 | 38.16B |
| June 30, 2023 | 51.85B |
| March 31, 2023 | 52.06B |
| December 31, 2022 | 59.34B |
| September 30, 2022 | 60.82B |
| June 30, 2022 | 62.92B |
| March 31, 2022 | 61.54B |
| December 31, 2021 | 67.66B |
| September 30, 2021 | 56.77B |
| June 30, 2021 | 54.04B |
| March 31, 2021 | 50.52B |
| December 31, 2020 | 56.60B |
| September 30, 2020 | 54.48B |
| June 30, 2020 | 53.81B |
| March 31, 2020 | 50.90B |
| December 31, 2019 | 55.47B |
| September 30, 2019 | 52.52B |
| June 30, 2019 | 51.43B |
| March 31, 2019 | 47.23B |
| December 31, 2018 | 78.61B |
| September 30, 2018 | 77.94B |
| June 30, 2018 | 76.82B |
| March 31, 2018 | 71.10B |
| December 31, 2017 | 74.17B |
| Date | Value |
|---|---|
| September 30, 2017 | 72.31B |
| June 30, 2017 | 69.92B |
| March 31, 2017 | 67.59B |
| December 31, 2016 | 74.83B |
| September 30, 2016 | 74.98B |
| June 30, 2016 | 72.46B |
| March 31, 2016 | 71.81B |
| December 31, 2015 | 77.05B |
| September 30, 2015 | 76.71B |
| June 30, 2015 | 78.76B |
| March 31, 2015 | 76.38B |
| December 31, 2014 | 70.77B |
| September 30, 2014 | 71.34B |
| June 30, 2014 | 70.39B |
| March 31, 2014 | 70.21B |
| December 31, 2013 | 74.34B |
| September 30, 2013 | 72.05B |
| June 30, 2013 | 69.49B |
| March 31, 2013 | 67.03B |
| December 31, 2012 | 69.14B |
| September 30, 2012 | 67.08B |
| June 30, 2012 | 64.13B |
| March 31, 2012 | 63.10B |
| December 31, 2011 | 65.84B |
| September 30, 2011 | 66.14B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
38.16B
Minimum
Sep 2023
67.66B
Maximum
Dec 2021
54.61B
Average
54.04B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Sandoz Group AG | -- |
| Amgen Inc | 6.232B |
| AstraZeneca PLC | 39.14B |
| Incyte Corp | 5.190B |
| MorphoSys AG | 54.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 99.94B |
| Total Liabilities (Quarterly) | 53.20B |
| Debt to Equity Ratio | 0.5254 |
| Current Ratio | 1.155 |
| Net Debt Paydown Yield | 0.22% |